Healthy Skepticism Library item: 12163

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Moore N, Juillet Y, Bertoye PH; Round Table No 4, Giens XXII.
Integrity of scientific data: transparency of clinical trial data.
Therapie 2007 May-Jun; 62:(3):203-9,
http://www.journal-therapie.org/index.php?option=article&access=doi&doi=10.2515/therapie:2007043

Abstract:

The integrity of the data from clinical trials and of its use is an essential element of the scientific method, and of the trust one can have in this method. There are many examples of fraud, and they recur regularly. The objective of this round table was to work on the definition of fraud, on its recognition and prevention especially in the institutional system. Fraud involves an active decision to cheat, and ranges from trying to hide incompetence to wholesale invention of data, patients or studies. Its frequency is difficult to evaluate but might be as high as 1% of all studies or publications. Fraud can involve ethics (post-hoc IRB [institutional review board] approval, IRB requests not applied, lack of consent), or any of the steps from realisation to interpretation of studies or trials. Identification of fraud is made harder by the usual risk for the whistle-blowers, who must be protected. Seeking fraud is implicit in Good Clinical Practices (GCP) that all industry sponsors must apply, but that are less often applied by institutional sponsors. It might be useful to install procedures to detect fraud in studies, especially institutional. Various statistical methods can be used to identify unusual data patterns that could suggest fraud. Once fraud is identified, its management is often not foreseen. Here again, clear procedures or recommendations would be of help.

Keywords:
Clinical Trials as Topic/ethics Clinical Trials as Topic/standards* Clinical Trials as Topic/statistics & numerical data* Data Interpretation, Statistical Drug Industry/ethics Drug Industry/standards Publications Scientific Misconduct*/ethics Scientific Misconduct*/legislation & jurisprudence Scientific Misconduct*/statistics & numerical data Terminology as Topic